Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole

Trichosporon species is an important life-threatening opportunistic systemic pathogen, especially in leukemia patients. Voriconazole is proved to be a promising agent in past decade. However, recently we observed a case of breakthrough Trichosporon asahii infection while receiving voriconazole, whic...

Full description

Bibliographic Details
Main Authors: Jia Chen, Feng Chen, Ying Wang, Ling-Yi Yang, Miao Miao, Yue Han, De-Pei Wu
Format: Article
Language:English
Published: Elsevier 2014-10-01
Series:Medical Mycology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221175391400044X
_version_ 1818279282377490432
author Jia Chen
Feng Chen
Ying Wang
Ling-Yi Yang
Miao Miao
Yue Han
De-Pei Wu
author_facet Jia Chen
Feng Chen
Ying Wang
Ling-Yi Yang
Miao Miao
Yue Han
De-Pei Wu
author_sort Jia Chen
collection DOAJ
description Trichosporon species is an important life-threatening opportunistic systemic pathogen, especially in leukemia patients. Voriconazole is proved to be a promising agent in past decade. However, recently we observed a case of breakthrough Trichosporon asahii infection while receiving voriconazole, which calls for an alternative treatment strategy. A combination therapy of liposomal amphotericin B (AmB) plus caspofungin – in which liposomal AmB dose was reduced due to renal toxicity – was administered to successfully treat this patient.
first_indexed 2024-12-12T23:30:51Z
format Article
id doaj.art-84ca0de7fdb84f67acb2d9956d699010
institution Directory Open Access Journal
issn 2211-7539
language English
last_indexed 2024-12-12T23:30:51Z
publishDate 2014-10-01
publisher Elsevier
record_format Article
series Medical Mycology Case Reports
spelling doaj.art-84ca0de7fdb84f67acb2d9956d6990102022-12-22T00:07:47ZengElsevierMedical Mycology Case Reports2211-75392014-10-016C555710.1016/j.mmcr.2014.09.003Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazoleJia Chen0Feng Chen1Ying Wang2Ling-Yi Yang3Miao Miao4Yue Han5De-Pei Wu6Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaRespiratory Department, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaTrichosporon species is an important life-threatening opportunistic systemic pathogen, especially in leukemia patients. Voriconazole is proved to be a promising agent in past decade. However, recently we observed a case of breakthrough Trichosporon asahii infection while receiving voriconazole, which calls for an alternative treatment strategy. A combination therapy of liposomal amphotericin B (AmB) plus caspofungin – in which liposomal AmB dose was reduced due to renal toxicity – was administered to successfully treat this patient.http://www.sciencedirect.com/science/article/pii/S221175391400044XT. asahiiLiposomal amphotericin BCaspofunginVoriconazole
spellingShingle Jia Chen
Feng Chen
Ying Wang
Ling-Yi Yang
Miao Miao
Yue Han
De-Pei Wu
Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
Medical Mycology Case Reports
T. asahii
Liposomal amphotericin B
Caspofungin
Voriconazole
title Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
title_full Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
title_fullStr Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
title_full_unstemmed Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
title_short Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
title_sort use of combination therapy to successfully treat breakthrough trichosporon asahii infection in an acute leukemia patient receiving voriconazole
topic T. asahii
Liposomal amphotericin B
Caspofungin
Voriconazole
url http://www.sciencedirect.com/science/article/pii/S221175391400044X
work_keys_str_mv AT jiachen useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT fengchen useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT yingwang useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT lingyiyang useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT miaomiao useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT yuehan useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole
AT depeiwu useofcombinationtherapytosuccessfullytreatbreakthroughtrichosporonasahiiinfectioninanacuteleukemiapatientreceivingvoriconazole